Pathogenic XPO1 variants cause a dominant neurodevelopmental disorder

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragen

Beitragende

  • Amber S E van Oirsouw - , Universitätsklinikum Utrecht (Autor:in)
  • Pavla Nedbalova - , University of South Bohemia (Autor:in)
  • Miroslava Hancarova - , Universitätskrankenhaus Motol (Autor:in)
  • Jan Prchal - , University of Chemistry and Technology, Prague (Autor:in)
  • Darina Prchalova - , Universitätskrankenhaus Motol (Autor:in)
  • Marketa Vlckova - , Universitätskrankenhaus Motol (Autor:in)
  • Sarka Bendova - , Universitätskrankenhaus Motol (Autor:in)
  • Kristin G Monaghan - , GeneDx (Autor:in)
  • Lisa M Dyer - , GeneDx (Autor:in)
  • Yanmin Chen - , GeneDx (Autor:in)
  • Deanna Alexis Carere - , GeneDx (Autor:in)
  • Emma A M Te Bogt - , Universitätsklinikum Utrecht (Autor:in)
  • Heather Fisher - , University of Texas Southwestern Medical Center (Autor:in)
  • Angela E Scheuerle - , University of Texas Southwestern Medical Center (Autor:in)
  • Stephanie Riley - , Kennedy Krieger Institute (Autor:in)
  • Mahim Jain - , Kennedy Krieger Institute (Autor:in)
  • Weiyi Mu - , Johns Hopkins Medicine (Autor:in)
  • Joann N Bodurtha - , Johns Hopkins Medicine (Autor:in)
  • Albertien M van Eerde - , Universitätsklinikum Utrecht (Autor:in)
  • Marijn F Stokman - , Radboud University Medical Center (Autor:in)
  • Nicola Longo - , University of California at San Diego (Autor:in)
  • Meena Balasubramanian - , Sheffield Children's NHS Foundation Trust, University of Sheffield (Autor:in)
  • Michael Spiller - , Sheffield Children's NHS Foundation Trust (Autor:in)
  • Gregory Costain - , University of Toronto, Hospital for Sick Children (Autor:in)
  • Charlotte von der Lippe - , South Eastern Norway Regional Health Authority (Autor:in)
  • Kristian Tveten - , South Eastern Norway Regional Health Authority (Autor:in)
  • Marianne Jortveit - , Sørlandet Sykehus Kristiansand (Autor:in)
  • Øystein L Holla - , South Eastern Norway Regional Health Authority (Autor:in)
  • Bertrand Isidor - , Université de Nantes, CHU de Nantes (Autor:in)
  • Benjamin Cogné - , Université de Nantes, CHU de Nantes (Autor:in)
  • Kevin E Glinton - , Baylor College of Medicine (Autor:in)
  • Blake Vuocolo - , Baylor College of Medicine (Autor:in)
  • Roberta Ann Sierra - , Baylor College of Medicine (Autor:in)
  • Brad Angle - , Advocate Aurora Health (Autor:in)
  • Kelly Bontempo - , Advocate Aurora Health (Autor:in)
  • Klaas Koop - , Universitätsklinikum Utrecht (Autor:in)
  • Rachel Rabin - , NYU Grossman School of Medicine (Autor:in)
  • John Pappas - , NYU Grossman School of Medicine (Autor:in)
  • David A Staffenberg - , New York University Langone Health (Autor:in)
  • Pascal Joset - , Universitätsspital Basel (Autor:in)
  • Peter Miny - , Universitätsspital Basel (Autor:in)
  • Isabel Filges - , Universitätsspital Basel (Autor:in)
  • Abdulrazak Alali - , West Virginia University (Autor:in)
  • Kara Vitalone - , Akron Children's Hospital (Autor:in)
  • Jill A Rosenfeld - , Baylor College of Medicine, Baylor Genetics, LLC (Autor:in)
  • Weimin Bi - , Baylor College of Medicine, Baylor Genetics, LLC (Autor:in)
  • Samuel Bradbrook - , University of Calgary (Autor:in)
  • Renee Perrier - , University of Calgary (Autor:in)
  • Subhadra Ramanathan - , Loma Linda University Health (Autor:in)
  • June-Anne Gold - , Loma Linda University Health, University of California at Irvine (Autor:in)
  • María Palomares Bralo - , European Reference Network for Rare Malformation Syndromes, Intellectual and Other Neurodevelopmental Disorders, Hospital Universitario La Paz (Autor:in)
  • María Ángeles Gómez-Cano - , Hospital Universitario La Paz (Autor:in)
  • Ann Haskins Olney - , University of Nebraska Medical Center (Autor:in)
  • Shelly Nielsen - , University of Nebraska Medical Center (Autor:in)
  • Alban Ziegler - , Département de Médecine Intensive (Autor:in)
  • Dominique Bonneau - , Département de Médecine Intensive (Autor:in)
  • Clément Prouteau - , Département de Médecine Intensive (Autor:in)
  • Ange-Line Bruel - , Hôpital du Bocage, CHU Dijon Bourgogne (Autor:in)
  • Charlotte Caille-Benigni - , Central Hospital of Troyes (Autor:in)
  • Laëtitia Lambert - , Central Hospital of Troyes, Université de Lorraine (Autor:in)
  • Andrea C Yu - , Centre hospitalier pour enfants de l'est de l'Ontario (Autor:in)
  • Nathaniel H Robin - , University of Alabama at Birmingham (Autor:in)
  • Dana Goodloe - , University of Alabama at Birmingham (Autor:in)
  • Jan Fischer - , Institut für Klinische Genetik (Autor:in)
  • Joseph Porrmann - , Institut für Klinische Genetik (Autor:in)
  • Yvonne D Hennig - , Universitätsklinikum Leipzig (Autor:in)
  • Rami Abou Jamra - , Universitätsklinikum Leipzig (Autor:in)
  • Isabella Herman - , Boys Town National Research Hospital (Autor:in)
  • Ivy R Johnson - , University of Nebraska Medical Center (Autor:in)
  • Lucas Hérissant - , Laboratoire National de Santé (Autor:in)
  • Guillaume Jouret - , Laboratoire National de Santé (Autor:in)
  • Koen L I van Gassen - , Universitätsklinikum Utrecht (Autor:in)
  • Ellen van Binsbergen - , Universitätsklinikum Utrecht (Autor:in)
  • Bert van der Zwaag - , Universitätsklinikum Utrecht (Autor:in)
  • Alwin Kamermans - , Universitätsklinikum Utrecht (Autor:in)
  • Renske Oegema - , Universitätsklinikum Utrecht (Autor:in)
  • Zdenek Sedlacek - , Universitätskrankenhaus Motol (Autor:in)
  • Michaela Fenckova - , University of South Bohemia (Autor:in)
  • Richard H van Jaarsveld - , Universitätsklinikum Utrecht (Autor:in)

Abstract

PURPOSE: XPO1 functions in key cellular processes, including nucleo-cytoplasmic export and mitosis. The gene is deleted in a subset of patients with the 2p15p16.1 microdeletion syndrome, however no monogenic XPO1-related disorder has been described to date.

MATERIALS AND METHODS: We collected clinical data of individuals with de novo XPO1 variants through online matchmaking. We employed Drosophila to study XPO1 function in development and habituation learning.

RESULTS: A total of 22 individuals met the criteria to be included in the main study cohort. Of these, half have putative loss-of-function variants and half have coding variants (10 missense and 1 in-frame deletion variant). We find an overlapping phenotype, consistent with a monogenic neurodevelopmental disorder (NDD). We demonstrate XPO1 functions in development by ubiquitous and neuron-specific knockdown in Drosophila. GABAergic neuron specific knockdown flies demonstrated impaired habituation.

CONCLUSION: Our results establish XPO1 as a novel dominant monogenic NDD gene and demonstrate a central role for XPO1 in development.

Details

OriginalspracheEnglisch
Aufsatznummer101555
FachzeitschriftGenetics in Medicine
Jahrgang27
Ausgabenummer11
Frühes Online-Datum13 Aug. 2025
PublikationsstatusVeröffentlicht - Nov. 2025
Peer-Review-StatusNein

Externe IDs

unpaywall 10.1016/j.gim.2025.101555
Scopus 105017402220

Schlagworte

ASJC Scopus Sachgebiete

Schlagwörter

  • Dominant inheritance, Habituation, Mendelian disorders, Monogenic NDD, XPO1